GLYC GlycoMimetics Inc

5,366

$1.64

$0.14

(9.33%)

Today

Watchers	5,366
52-Wk Low	$1.11
52-Wk High	$4.16

Market Cap	$96.59M
Volume (M)	833.00
52-Wk High	$4.16
52-Wk Low	$1.11

Fundamentals

Contrasting GB Sciences (OTCMKTS:GBLX) and GlycoMimetics (NASDAQ:GLYC)Zolmax • 5 days ago

GB Sciences (OTCMKTS:GBLX Get Free Report) and GlycoMimetics (NASDAQ:GLYC Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies...

Share to Feed

GlycoMimetics to Participate in Upcoming Jefferies London Healthcare ConferenceBusiness Wire • 22 days ago

GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that Harout Semerjian, Chief Executive Officer, will participate in a fireside chat at the Jefferies London Healthcare Conference in London, UK on...

GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2023Business Wire • 28 days ago

GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today reported its...

GlycoMimetics, Inc. (GLYC) Q3 2023 Earnings Call TranscriptSeekingAlpha • 28 days ago

GlycoMimetics, Inc. (GLYC) Q3 2023 Earnings Call Transcript...

GlycoMimetics Inc (GLYC) Reports Q3 2023 Financial ResultsGuruFocus • 28 days ago

Company's Cash and Cash Equivalents Stand at $49.4 Million as of September 30, 2023Related Stocks: GLYC...

Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory BoardPR Newswire • about 1 month ago

Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board Anixa Biosciences Appoints Accomplished Medical...

GlycoMimetics to Report Third Quarter 2023 Financial Results on November 3, 2023Business Wire • about 1 month ago

GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report third quarter 2023 financial results on Friday, November 3, 2023, at 8:30 a.m. ET. To...

GlycoMimetics (NASDAQ:GLYC) Earns Hold Rating from Analysts at StockNews.comTicker Report • about 2 months ago

Analysts at StockNews.com began coverage on shares of GlycoMimetics (NASDAQ:GLYC Get Free Report) in a research report issued to clients and investors on Thursday. The brokerage set a...

Edwin Rock Acquires 35,000 Shares of GlycoMimetics, Inc. (NASDAQ:GLYC) StockZolmax • 2 months ago

GlycoMimetics, Inc. (NASDAQ:GLYC Get Free Report) insider Edwin Rock bought 35,000 shares of the companys stock in a transaction dated Thursday, September 21st. The stock was purchased...

GlycoMimetics doses first cohort in GMI-1687 studyThe Fly • 3 months ago

See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...